Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-28 4:53 pm Sale | 2023-11-17 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 2,410,524 9.900% | -102,227 (-4.07%) | Filing History |
| 2023-08-28 1:46 pm Purchase | 2023-08-25 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 7,333,334 9.800% | 6,780,044 (+1225.41%) | Filing History |
| 2023-07-27 6:09 pm Purchase | 2023-07-11 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 429,000 5.800% | 429,000 (New Position) | Filing History |
| 2023-06-07 5:33 pm Purchase | 2023-06-01 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 8,988,318 9.900% | 8,988,318 (New Position) | Filing History |
| 2023-02-15 3:19 pm Purchase | 2022-12-31 | 13G | SIENTRA INC SIENQ | Rosalind Advisors Inc. | 509,274 5.000% | 509,274 (New Position) | Filing History |
| 2023-02-15 1:16 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors Inc. | 2,499,993 4.200% | 314,329 (+14.38%) | Filing History |
| 2023-02-13 5:53 pm Unchanged | 2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 2,158,272 9.970% | 0 (Unchanged) | Filing History |
| 2022-12-21 12:37 pm Purchase | 2022-12-02 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 444,326 6.100% | 444,326 (New Position) | Filing History |
| 2022-12-21 12:17 pm Purchase | 2022-12-13 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 2,512,751 9.900% | 692,042 (+38.01%) | Filing History |
| 2022-11-02 8:03 pm Purchase | 2022-10-25 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 2,158,272 9.970% | 1,553,044 (+256.60%) | Filing History |
| 2022-07-21 3:52 pm Purchase | 2022-07-18 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 1,820,709 9.900% | 566,751 (+45.20%) | Filing History |
| 2022-07-06 4:34 pm Purchase | 2022-06-22 | 13G | Guided Therapeutics, Inc. GTHP | Rosalind Advisors Inc. | 2,338,740 8.300% | 2,338,740 (New Position) | Filing History |
| 2022-03-09 5:09 pm Purchase | 2022-02-28 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors Inc. | 2,185,664 8.500% | 2,185,664 (New Position) | Filing History |
| 2022-03-09 4:45 pm Unchanged | 2021-12-31 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 1,253,958 9.900% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:09 pm Unchanged | 2021-12-31 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 1,253,958 9.900% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:12 pm Sale | 2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Rosalind Advisors Inc. | 707,467 1.500% | -1,900,390 (-72.87%) | Filing History |
| 2022-02-14 3:15 pm Sale | 2021-12-31 | 13G | PLX PHARMA INC PLXPQ | Rosalind Advisors Inc. | 0 0.000% | -970,425 (Position Closed) | Filing History |
| 2022-02-11 5:14 pm Purchase | 2022-02-04 | 13G | Galera Therapeutics, Inc. GRTX | Rosalind Advisors Inc. | 1,543,783 5.800% | 1,543,783 (New Position) | Filing History |
| 2022-01-21 3:49 pm Purchase | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 605,228 9.970% | 284,512 (+88.71%) | Filing History |
| 2022-01-20 4:23 pm Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Rosalind Advisors Inc. | 969,484 6.500% | 156,929 (+19.31%) | Filing History |